ACUMEN PHARMACEUTICALS, INC.
ACU193, a humanized monoclonal antibody selective for amyloid-beta oligomers for Alzheimer's disease diagnosis and monitoring
- Sector
- Biotech
- Headquarters
- LIVERMORE, CA
- Latest Form D
- $700K, May 2013
- Total capital
- $922K
- Federal grants
- $222K
- 1 award · 2016
- Rank in peer group#337 of 392
- Private capital raised
- $700K
- 1 Form D · last May 2013
- 161 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 6 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Development of a non-fibrillic amyloid-beta oligomer selective positron emission tomography imaging diagnostic for Alzheimer.$222K
- Private capital raisedForm D · SEC · 1st filing$700K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 392 peers
Line = medianBiotech · Molecule
- Federal grantsBelow median
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Daniel J. O'ConnellExecutive Officer, DirectorNamed in SEC Form D filings
- David W. SummaDirectorNamed in SEC Form D filings
- Franz HeftiDirector, PromoterNamed in SEC Form D filings
- Grant KrafftDirectorNamed in SEC Form D filings
- Jurgen W. WeberDirectorNamed in SEC Form D filings
- Mark LampertDirectorNamed in SEC Form D filings
Show all 7 people
- William F. GoureExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 6- PendingMonoclonal Antibodies That Target Pathological Assemblies Of Amyloid Beta (abeta)USPTOApplication 13943031
- PendingAmyloid Beta Peptides, Assemblies Thereof, And Related MethodsUSPTOApplication 13676626
- PendingNovel Addl Receptor Polypeptides, Polynucleotides And Host Cells For Recombinant ProductionUSPTOApplication PCTUS2008087196
Show all 6 patent records
- Monoclonal Antibodies That Target Pathological Assemblies Of Amyloid Beta (abeta)Dec 12, 2013 · Application 13943031Pending
- Amyloid Beta Peptides, Assemblies Thereof, And Related MethodsMar 28, 2013 · Application 13676626Pending
- Novel Addl Receptor Polypeptides, Polynucleotides And Host Cells For Recombinant ProductionApplication PCTUS2008087196Pending
- Methods Of Inhibiting The Formation Of Amyloid-b Diffusable Ligands Using Acylhydrazide CompoundsApplication PCTUS2008069878Pending
- Methods Of Modifying Amyloid Beta Oligomers Using Non-peptidic CompoundsApplication PCTUS2007073408Pending
- Methods Of Enhancing Cognitive Function Using Non-peptidic CompoundsApplication PCTUS2007073410Pending
Related companies, and why
- Nok Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- SENTRIMED, INC.Similar federal contract value in Biotech · null in contracts
- Oleander Medical Technologies LLCSimilar federal contract value in Biotech · null in contracts
- StrideBio, Inc.Similar federal contract value in Biotech · null in contracts
- Alveus Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- ARIDIS PHARMACEUTICALS, LLCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .